trade

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...ings without the need forroutine monitoring." The trade name of rivaroxaban is expected to be Xarelto®,pending health authority approval. Additional Phase III results of the ongoing RECORD program areexpected to be available during H2 2007. Unmet Needs in Venous Thromboembolism (VTE) VTE is a type o...

Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery

...risk for life-threatening thrombotic events." The trade name of rivaroxaban is expected to be Xarelto(R),pending health authority approval. Results from other phase III trials in the RECORD program,RECORD1 and RECORD2 are expected to be available by H2 2007. Unmet Needs in Venous Thromboembolism (VTE) ...

Cytokinetics Reports Additional Clinical Trials Data for Ispinesib

...cs may not be able to obtain and maintainpatent or trade secret protection for its intellectual property;that Cytokinetics may incur unanticipated research and developmentand other costs or be unable to obtain additional financing ifnecessary; and that standards of care may change or others mayintroduce pr...

Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Company's Dermal Drug Delivery Technology

...h the Bank of New York (PPGNY) for US investors to trade inPhosphagenics' stock on the "over-the-counter" market. For more information, please visit Phosphagenics' web site at<a target="_blank" href="http://www.phosphagenics.com/">http://www.phosphagenics.com CONTACT: Company, Dr. Esra Ogru, Exe...

Enbrel Safety Data for up to Eight Years in Patients with Juvenile Rheumatoid Arthritis Being Presented at EULAR

...hanges ingenerally accepted accounting principles; trade buying patterns;the impact of legislation and regulatory compliance; risks anduncertainties associated with global operations and sales; andother risks and uncertainties, including those detailed from timeto time in our periodic reports filed with th...

Mymetics' HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model

...rland (Nyon, near Geneva). Mymetics Common shares trade on NASDAQ's OTC:PK under the symbolMYMX. For more information, please visit the Company's website at<a target="_blank" href="http://www.mymetics.com/">http://www.mymetics.com/ . Forward-Looking Statements The Private Securities Litigation R...

Archimedes Pharma Presents Positive Efficacy and Safety Data on Nasalfent at European Association for Palliative Care Congress

...ts with breakthrough cancer pain." Nasalfent is a trade mark of Archimedes and are registered asCTM, and US Registered Trademarks and in certain otherjurisdictions. Enquiries Archimedes Pharma: Michael Clark, +44 118 931 5050,+44 7973 111683 Citigate Dewe Rogerson: Chris Gardner, +44 (0)207638 9571 For m...

Caelyx Delays Time to Disease Progression as Maintenance Therapy in Patients with Metastatic Breast Cancer

... product is marketed in the United Statesunder the trade name DOXIL® by Ortho Biotech Products,L.P. Imp...d futurebranded and generic competition, timing of trade buying, anddifficulties in product development, among otheruncertainties. For further details about...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

...d future branded andgeneric competition, timing of trade buying, and difficulties inproduct development, among other uncertainties. For furtherdetails about these and other factors that may impact theforward-looking statements, see Schering- Plough's Securities andExchange Commission filings, including it...

Positive Final Data from HyCAMP Phase II Trial in Metastatic Colorectal

... and 2009 in the EU. Camptosar(R) is a registered trade mark of Pfizer Inc. About HyCAMP(TM) HyCAMP(TM) is a proprietary formulation of the anti-cancer drugCamptosar(R) with HA. Preclinical studies with HyCAMP(TM)demonstrated improved delivery of the drug to the tumour, resultingin increased efficacy an...

New Data Focuses on Abuse of Stimulant Medication

...ric patients with autism. OROS(r) is a registered trade mark of ALZA Corporation. --------------------------------------------------------- [1] The number of prescriptions for OROS MPH(r) and other MPHtreatments was similar (=28 vs 25 milllion), yet OROS MPH(r)accounted for 23% of DAWN reports while oth...

Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

...r regulatory review in the UnitedStates, including trade name review. “All combinations of amlodipine and olmesartan producedsignificantly greater mean reductions in both diastolic andsystolic blood pressure than either medication alone,” saidSteven G. Chrysant, MD, of the Oklahoma ...

New Data Suggests Less Abuse-Related Effects For OROS Methylphenidate

...ric patients with autism. OROS(R) is a registered trade mark of ALZA Corporation. (1) The number of prescriptions for OROS MPH(R) and other MPHtreatments was similar (=28 vs 25 million), yet OROS MPH(R)accounted for 23% of DAWN reports while other MPH formulationsaccounted for 77%. The ratio of abuse rep...

New Long-Term Data Analyses for Bifeprunox Show Favorable Effects Versus Placebo in Stabilized Patients with Schizophrenia

...hanges ingenerally accepted accounting principles; trade buying patterns;the impact of legislation and regulatory compliance; risks anduncertainties associated with global operations and sales; andother risks and uncertainties, including those detailed from timeto time in our periodic reports filed with th...

New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder

...les, the impact ofcompetitive or generic products, trade buying patterns, globalbusiness operations, product liability and other types oflitigation, the impact of legislation and regulatory compliance,intellectual property rights, strategic relationships with thirdparties, environmental liabilities, and ot...

Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo

...les, the impact ofcompetitive or generic products, trade buying patterns, globalbusiness operations, product liability and other types oflitigation, the impact of legislation and regulatory compliance,intellectual property rights, strategic relationships with thirdparties, environmental liabilities, and ot...

FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility

...hanges ingenerally accepted accounting principles; trade buying patterns;the impact of legislation and regulatory compliance; risks anduncertainties associated with global operations and sales; andother risks and uncertainties, including those detailed from timeto time in our periodic reports filed with th...

Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)

... regulatory review in the United States, including trade namereview. "All combinations of amlodipine and olmesartan producedsignificantly greater mean reductions in both diastolic andsystolic blood pressure than either medication alone," said StevenG. Chrysant, MD, of the Oklahoma Cardiovascular and Hyper...

Wyeth Presents Phase 3 Data for Pristiq, an Investigational Non-Hormonal Therapy for Menopausal Hot Flashes and Night Sweats

...hanges in generally acceptedaccounting principles; trade buying patterns; the impact oflegislation and regulatory compliance; risks and uncertaintiesassociated with global operations and sales; and other risks anduncertainties, including those detailed from time to time in ourperiodic reports filed with th...

Clinical Trial Results Suggest Long-Term Treatment Benefit of Tetrabenazine for Chorea Associated with Huntington's Disease

...cation with the FDA to market the productunder the trade name XENAZINE, and review of the application ispending. About Prestwick Pharmaceuticals Prestwick is a late-stage product-based biopharmaceuticalcompany engaged in the development and marketing of drugs fordiseases of the CNS. The portfolio of drug...

Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter

...ththe Bank of New York (PPGNY) for US investors to trade inPhosphagenics' stock on the 'over-the-counter' market. For more information, please visit Phosphagenics' web site at<a target="_blank" href="http://www.phosphagenics.com/">http://www.phosphagenics.com CONTACT: Company - Dr. Esra Ogru, Ex...

Data Presented at the American Academy of Neurology's Annual Meeting Provide Update on Utilization and Safety of Tysabri in Patients with Multiple Sclerosis

...hat continue toexist around the world. Elan shares trade on the New York, Londonand Dublin Stock Exchanges. For additional information about thecompany, please visit www.elan.com. Safe Harbor/Forward Looking Statements This press release contains forward-looking statements regardingTYSABRI. These stateme...

Evaluating the Efficacy and Safety of Once-Daily Anti-Inflammatory Dose Doxycycline for the Treatment of Rosacea

...mark of CollaGenexPharmaceuticals, Inc. All other trade names, trademarks or service marks are theproperty of their respective owners and are not the property ofCollaGenex Pharmaceuticals, Inc. or any of our subsidiaries. Novacort(R) and Alcortin(R) are trademarks of PrimusPharmaceuticals, Inc. Pandel(R...

Cytokinetics Announces Non-clinical Data to be Presented at the 2007 AACR Annual Meeting

...cs may not be able to obtain and maintainpatent or trade secret protection for its intellectual property;Cytokinetics may incur unanticipated research and development andother costs or be unable to obtain additional financing ifnecessary; and standards of care may change or others may introduceproducts or ...

New Analysis of Data from WHI Provides Reassurance With Respect to Coronary Heart Disease For Newly Menopausal Women Considering Hormone Therapy

...hanges ingenerally accepted accounting principles; trade buying patterns;the impact of legislation and regulatory compliance; risks anduncertainties associated with global operations and sales; andother risks and uncertainties, including those detailed from timeto time in our periodic reports filed with th...

Safety Analyses of Clinical Data for Bifeprunox in Patients with Schizophrenia Showed a Favorable Weight and Lipid Profile, Similar to Placebo

...hanges ingenerally accepted accounting principles; trade buying patterns;the impact of legislation and regulatory compliance; risks anduncertainties associated with global operations and sales; andother risks and uncertainties, including those detailed from timeto time in our periodic reports filed with th...

Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting Protective Antibody Response in Mucosal Tissues of Non-Human Primate Model

...rland (Nyon, near Geneva). Mymetics Common shares trade on NASDAQ's OTC:PK under the symbolMYMX. For more information, please visit the Company's website at<a target="_blank" href="http://www.mymetics.com/">http://www.mymetics.com/ . Forward-Looking Statements The Private Securities Litigation R...

CSL Therapy That Mimics 'Good' Cholesterol May Reduce Plaque Volume in Coronary Arteries

...countries; difficulties or delaysin manufacturing; trade buying patterns, fluctuations in interestand currency exchange rates; legislation or regulations throughoutthe world that affect product production, distribution, pricing,reimbursement or access; legal defense costs, insurance expenses,settlement cos...

IR BioSciences Announces Data Demonstrating Radilex Stimulation of Stem Cells Results in Hematopoietic Recovery Following Lethal Irradiation

...t Radilex(TM) and Viprovex(TM) Radilex(TM) is the trade name used in referring to formulationsof Homspera(...exposureto ionizing radiation. Viprovex(TM) is the trade name used inreferring to formulations of Homspera for potential indications fortreatment of viral an...